流感诱导的血小板减少症取决于病毒亚型与唾液酸聚糖受体,并随病毒致病性增强而加重
甲型H1N1流感患者急性感染期病毒载量与血小板计数呈负相关,雪貂模型显示血小板下降程度随病毒致病性从H3N2的0%到H1N1大流行株的22%再到高致病性H5N1的62%递增。血小板通过唾液酸聚糖结合摄取流感病毒颗粒,病毒神经氨酸酶去除唾液酸触发肝脏清除血小板,作者提出血小板清除流感病毒的范式。
要点
- 甲型H1N1流感患者急性期病毒载量与血小板计数呈负相关。
- 雪貂模型中血小板下降程度随病毒致病性增强而加重,H3N2为0%、H1N1大流行株为22%、H5N1为62%。
- 血小板通过唾液酸聚糖结合摄取病毒,病毒神经氨酸酶去除唾液酸触发肝脏清除血小板。
核心结论
- 流感诱导的血小板减少症取决于病毒亚型和唾液酸聚糖受体,并随病毒致病性增强而加重。
- 作者提出血小板清除流感病毒作为范式,并提示严重呼吸道感染(包括COVID-19)可能促进血小板减少和/或血栓栓塞并发症。
研究设计与样本
- 研究纳入甲型H1N1流感病毒感染患者,并在雪貂流感病毒感染模型中验证。
主要发现
- 甲型H1N1流感患者急性感染期病毒载量与血小板计数呈负相关。
- 雪貂模型中,血小板计数下降程度随病毒致病性不同:H3N2感染动物为0%,H1N1大流行株感染动物为22%,高致病性H5N1感染动物为62%。
- 血小板减少与血液中循环的含病毒血小板相关。
- 血小板摄取流感病毒颗粒需要结合唾液酸聚糖,病毒神经氨酸酶去除唾液酸,触发肝脏清除血小板。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombocytopenia is a common complication of influenza virus infection, and its severity predicts the clinical outcome of critically ill patients. The underlying cause(s) remain incompletely understood. In this study, in patients with an influenza A/H1N1 virus infection, viral load and platelet count correlated inversely during the acute infection phase. We confirmed this finding in a ferret model of influenza virus infection. In these animals, platelet count decreased with the degree of virus pathogenicity varying from 0% in animals infected with the influenza A/H3N2 virus, to 22% in those with the pandemic influenza A/H1N1 virus, up to 62% in animals with a highly pathogenic A/H5N1 virus infection. This thrombocytopenia is associated with virus-containing platelets that circulate in the blood. Uptake of influenza virus particles by platelets requires binding to sialoglycans and results in the removal of sialic acids by the virus neuraminidase, a trigger for hepatic clearance of platelets. We propose the clearance of influenza virus by platelets as a paradigm. These insights clarify the pathophysiology of influenza virus infection and show how severe respiratory infections, including COVID-19, may propagate thrombocytopenia and/or thromboembolic complications.
引用
- Jansen AJG, Spaan T, Low HZ, et al. Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity. Blood Adv. 2020. PMID: 32609845. doi:10.1182/bloodadvances.2020001640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。